Evaluation of glycemic abnormalities in children and adolescents with β-thalassemia major
Open Access
- 8 March 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Egyptian Pediatric Association Gazette
- Vol. 69 (1), 1-7
- https://doi.org/10.1186/s43054-021-00052-4
Abstract
Background The quality of life of B-thalassemia major (β-TM) patients has improved with the use of frequent blood transfusions. However, this leads to chronic iron overload with its sequelae, as prediabetes and diabetes mellitus. This study aimed to assess insulin resistance and glucose abnormalities in a sample of B-thalassemia major patients in Benha, Egypt. Results This case-control study included 40 B-thalassemia major patients on regular blood transfusion and iron chelation. Their ages ranged from 8 to 16 years, and 30 normal age and sex-matched controls. Thorough clinical examination was performed including weight (kg), height (m), body mass index (BMI) (kg/m2), and liver and spleen size. Laboratory investigations were done in the form of complete blood count, liver enzymes, serum ferritin, fasting plasma insulin, and fasting, and 2 h postprandial plasma glucose. Insulin resistance (IR) was calculated using the Homeostasis Model Assessment of insulin resistance (HOMA-IR) index. Insulin resistance was found in 27.5% of thalassemic patients; 18.2% of them had diabetes, 72.7% were prediabetics (with impaired fasting glycemia), and 9.1% had normal fasting and 2 h postprandial plasma glucose level. Insulin resistance increased significantly with increased blood transfusion duration, serum ferritin, liver enzymes, fasting plasma insulin, fasting plasma glucose, and 2 h postprandial plasma glucose (ROC). The curve analysis showed that the duration of blood transfusion, serum ferritin, fasting plasma insulin, fasting, and 2 h postprandial plasma glucose could significantly predict insulin resistance at a certain cut-off point. Conclusion Our data show that HOMA-IR can be used to detect insulin resistance in β-TM patients on long-term blood transfusions, especially patients with high serum ferritin and impaired liver enzymes.Keywords
This publication has 19 references indexed in Scilit:
- Effect of long-term transfusion therapy on the glycometabolic status and pancreatic beta cell function in patients with beta Thalassemia majorJournal of Family Medicine and Primary Care, 2014
- Detection of glycemic abnormalities in adolescents with beta thalassemia using continuous glucose monitoring and oral glucose tolerance in adolescents and young adults with β-thalassemia major: Pilot studyIndian Journal of Endocrinology and Metabolism, 2013
- Iron overload in non-transfusion-dependent thalassemia: a clinical perspectiveBlood Reviews, 2012
- Growth and endocrine function in thalassemia major in childhood and adolescenceJournal of Endocrinological Investigation, 2010
- Abnormal Glucose Tolerance in β-Thalassemia: Assessment of Risk FactorsHemoglobin, 2009
- The Role of Iron in Diabetes and Its ComplicationsDiabetes Care, 2007
- High prevalence of abnormal glucose homeostasis secondary to decreased insulin secretion in individuals with hereditary haemochromatosisDiabetologia, 2006
- Diagnosis and Classification of Diabetes MellitusDiabetes Care, 2004
- Diabetes, Plasma Insulin, and Cardiovascular DiseaseArchives of Internal Medicine, 2002
- Relation Between Antioxidant Enzyme Gene Expression and Antioxidative Defense Status of Insulin-Producing CellsDiabetes, 1997